{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:25:39Z","timestamp":1760909139304,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PGPM"],"DOI":"10.2147\/pgpm.s172467","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T18:47:32Z","timestamp":1541011652000},"page":"193-203","source":"Crossref","is-referenced-by-count":1,"title":["Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-8973","authenticated-orcid":true,"given":"Nadica","family":"Matevska-Geshkovska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Staninova-Stojovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kapedanovska-Nestorovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalija","family":"Petrushevska-Angelovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milco","family":"Panovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Grozdanovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Mitreski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Dimovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11]]},"container-title":["Pharmacogenomics and Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=45870","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=45870","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T18:47:33Z","timestamp":1541011653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/influence-of-msi-and-18q-loh-markers-on-capecitabine-adjuvant-monother-peer-reviewed-article-PGPM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/pgpm.s172467","relation":{},"ISSN":["1178-7066"],"issn-type":[{"type":"electronic","value":"1178-7066"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}